Clinical Trial Update: Immunotherapy Study of Evofosfamide in Combination With Ipilimumab [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update on evofosfamide in combination with ipilimumab for cancer treatment. The study targets pancreatic cancer, melanoma, squamous cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Pancreatic Cancer
• Prostate Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Evofosfamide (evofosfamide)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Threshold Pharmaceuticals | Conditions: Pancreatic Cancer, Melanoma | Phase 1 | Status: UNKNOWN